These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 19145988)

  • 1. Recombinant T cell receptor ligands: immunomodulatory, neuroprotective and neuroregenerative effects suggest application as therapy for multiple sclerosis.
    Offner H; Sinha S; Wang C; Burrows GG; Vandenbark AA
    Rev Neurosci; 2008; 19(4-5):327-39. PubMed ID: 19145988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A promising therapeutic approach for multiple sclerosis: recombinant T-cell receptor ligands modulate experimental autoimmune encephalomyelitis by reducing interleukin-17 production and inhibiting migration of encephalitogenic cells into the CNS.
    Sinha S; Subramanian S; Proctor TM; Kaler LJ; Grafe M; Dahan R; Huan J; Vandenbark AA; Burrows GG; Offner H
    J Neurosci; 2007 Nov; 27(46):12531-9. PubMed ID: 18003831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen-specific therapy promotes repair of myelin and axonal damage in established EAE.
    Wang C; Gold BG; Kaler LJ; Yu X; Afentoulis ME; Burrows GG; Vandenbark AA; Bourdette DN; Offner H
    J Neurochem; 2006 Sep; 98(6):1817-27. PubMed ID: 16899071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monomeric recombinant TCR ligand reduces relapse rate and severity of experimental autoimmune encephalomyelitis in SJL/J mice through cytokine switch.
    Huan J; Subramanian S; Jones R; Rich C; Link J; Mooney J; Bourdette DN; Vandenbark AA; Burrows GG; Offner H
    J Immunol; 2004 Apr; 172(7):4556-66. PubMed ID: 15034073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine switch and bystander suppression of autoimmune responses to multiple antigens in experimental autoimmune encephalomyelitis by a single recombinant T-cell receptor ligand.
    Sinha S; Subramanian S; Miller L; Proctor TM; Roberts C; Burrows GG; Vandenbark AA; Offner H
    J Neurosci; 2009 Mar; 29(12):3816-23. PubMed ID: 19321778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant TCR ligand induces tolerance to myelin oligodendrocyte glycoprotein 35-55 peptide and reverses clinical and histological signs of chronic experimental autoimmune encephalomyelitis in HLA-DR2 transgenic mice.
    Vandenbark AA; Rich C; Mooney J; Zamora A; Wang C; Huan J; Fugger L; Offner H; Jones R; Burrows GG
    J Immunol; 2003 Jul; 171(1):127-33. PubMed ID: 12816990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of encephalitogenic T cells with recombinant TCR ligands.
    Burrows GG; Adlard KL; Bebo BF; Chang JW; Tenditnyy K; Vandenbark AA; Offner H
    J Immunol; 2000 Jun; 164(12):6366-71. PubMed ID: 10843691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of autoimmune anterior uveitis with recombinant TCR ligands.
    Adamus G; Burrows GG; Vandenbark AA; Offner H
    Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2555-61. PubMed ID: 16723470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RTL therapy for multiple sclerosis: a Phase I clinical study.
    Offner H; Sinha S; Burrows GG; Ferro AJ; Vandenbark AA
    J Neuroimmunol; 2011 Feb; 231(1-2):7-14. PubMed ID: 20965577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MHC class II derived recombinant T cell receptor ligands protect DBA/1LacJ mice from collagen-induced arthritis.
    Huan J; Kaler LJ; Mooney JL; Subramanian S; Hopke C; Vandenbark AA; Rosloniec EF; Burrows GG; Offner H
    J Immunol; 2008 Jan; 180(2):1249-57. PubMed ID: 18178865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A GMCSF-Neuroantigen Tolerogenic Vaccine Elicits Systemic Lymphocytosis of CD4
    Moorman CD; Curtis AD; Bastian AG; Elliott SE; Mannie MD
    Front Immunol; 2018; 9():3119. PubMed ID: 30687323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective arylpiperazine dopaminergic/serotonergic ligands suppress experimental autoimmune encephalomyelitis in rats.
    Popovic M; Stanojevic Z; Tosic J; Isakovic A; Paunovic V; Petricevic S; Martinovic T; Ciric D; Kravic-Stevovic T; Soskic V; Kostic-Rajacic S; Shakib K; Bumbasirevic V; Trajkovic V
    J Neurochem; 2015 Oct; 135(1):125-38. PubMed ID: 26083644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monomeric DR2/MOG-35-55 recombinant TCR ligand treats relapses of experimental encephalomyelitis in DR2 transgenic mice.
    Link JM; Rich CM; Korat M; Burrows GG; Offner H; Vandenbark AA
    Clin Immunol; 2007 Apr; 123(1):95-104. PubMed ID: 17257899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The myelin-associated oligodendrocytic basic protein region MOBP15-36 encompasses the immunodominant major encephalitogenic epitope(s) for SJL/J mice and predicted epitope(s) for multiple sclerosis-associated HLA-DRB1*1501.
    de Rosbo NK; Kaye JF; Eisenstein M; Mendel I; Hoeftberger R; Lassmann H; Milo R; Ben-Nun A
    J Immunol; 2004 Jul; 173(2):1426-35. PubMed ID: 15240739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous system.
    Yan SS; Wu ZY; Zhang HP; Furtado G; Chen X; Yan SF; Schmidt AM; Brown C; Stern A; LaFaille J; Chess L; Stern DM; Jiang H
    Nat Med; 2003 Mar; 9(3):287-93. PubMed ID: 12598893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Properties of myelin altered peptide ligand cyclo(87-99)(Ala91,Ala96)MBP87-99 render it a promising drug lead for immunotherapy of multiple sclerosis.
    Deraos G; Rodi M; Kalbacher H; Chatzantoni K; Karagiannis F; Synodinos L; Plotas P; Papalois A; Dimisianos N; Papathanasopoulos P; Gatos D; Tselios T; Apostolopoulos V; Mouzaki A; Matsoukas J
    Eur J Med Chem; 2015 Aug; 101():13-23. PubMed ID: 26112377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic immunomodulation of autoimmune disease using MHC-derived recombinant TCR ligands.
    Burrows GG
    Curr Drug Targets Inflamm Allergy; 2005 Apr; 4(2):185-93. PubMed ID: 15853741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
    Prinz J; Karacivi A; Stormanns ER; Recks MS; Kuerten S
    PLoS One; 2015; 10(12):e0144847. PubMed ID: 26658811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis and their application for new therapeutic strategies.
    Martin R
    J Neural Transm Suppl; 1997; 49():53-67. PubMed ID: 9266414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obinutuzumab-Induced B Cell Depletion Reduces Spinal Cord Pathology in a CD20 Double Transgenic Mouse Model of Multiple Sclerosis.
    Breakell T; Tacke S; Schropp V; Zetterberg H; Blennow K; Urich E; Kuerten S
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.